92 related articles for article (PubMed ID: 29757443)
1. Impact of Genetic Polymorphism in the β2-Receptor Gene on Risk of Severe Hypoglycemia in Patients With Type 1 Diabetes.
Rokamp KZ; Olsen NV; Færch L; Kristensen PL; Thorsteinsson B; Pedersen-Bjergaard U
J Clin Endocrinol Metab; 2018 Aug; 103(8):2901-2908. PubMed ID: 29757443
[TBL] [Abstract][Full Text] [Related]
2. The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus.
Schouwenberg BJ; Veldman BA; Spiering W; Coenen MJ; Franke B; Tack CJ; de Galan BE; Smits P
Pharmacogenet Genomics; 2008 Apr; 18(4):369-72. PubMed ID: 18334922
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of impaired awareness of hypoglycemia in type 1 diabetes.
Schouwenberg BJ; Coenen MJ; Paterson AD; Tack CJ; Smits P; Kramers C; de Galan BE
Pharmacogenet Genomics; 2017 Sep; 27(9):323-328. PubMed ID: 28692628
[TBL] [Abstract][Full Text] [Related]
4. Impact of Polymorphism in the β2-Receptor Gene on the Metabolic Response to Epinephrine After Repeated Hypoglycemia.
Rokamp KZ; Dela F; Secher NH; Grønlykke L; Thorsteinsson B; Pedersen-Bjergaard U
Diabetes; 2023 Jun; 72(6):728-734. PubMed ID: 36913730
[TBL] [Abstract][Full Text] [Related]
5. The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and hypoglycemia awareness in patients with type 1 diabetes.
Holstein A; Plaschke A; Böttcher Y; Stumvoll M; Kovacs P
Horm Metab Res; 2006 Sep; 38(9):603-6. PubMed ID: 16981144
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
Pedersen-Bjergaard U; Dhamrait SS; Sethi AA; Frandsen E; Nordestgaard BG; Montgomery HE; Pramming S; Hougaard P; Thorsteinsson B
Am J Med; 2008 Mar; 121(3):246.e1-8. PubMed ID: 18328310
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
[TBL] [Abstract][Full Text] [Related]
9. Associations of beta2-adrenergic receptor genotypes and haplotypes with wheezing illness in Taiwanese schoolchildren.
Lee YL; Wang ST; Tsai CH; Guo YL
Allergy; 2009 Oct; 64(10):1451-1457. PubMed ID: 19254291
[TBL] [Abstract][Full Text] [Related]
10. Impact of Polymorphism in the β2-Receptor Gene on Metabolic Responses to Repeated Hypoglycemia in Healthy Humans.
Rokamp KZ; Holst JJ; Olsen NV; Dela F; Secher NH; Juul A; Faber J; Wiberg S; Thorsteinsson B; Pedersen-Bjergaard U
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3194-e3205. PubMed ID: 35552407
[TBL] [Abstract][Full Text] [Related]
11. Influence of β
Kelley EF; Cross TJ; Snyder EM; McDonald CM; ; Hoffman EP; Bello L
Respir Res; 2019 Oct; 20(1):221. PubMed ID: 31619245
[TBL] [Abstract][Full Text] [Related]
12. Genotype related differences in beta2 adrenergic receptor density and cardiac function.
Snyder EM; Hulsebus ML; Turner ST; Joyner MJ; Johnson BD
Med Sci Sports Exerc; 2006 May; 38(5):882-6. PubMed ID: 16672841
[TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
15. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.
Eisenach JH; McGuire AM; Schwingler RM; Turner ST; Joyner MJ
Physiol Genomics; 2004 Feb; 16(3):323-8. PubMed ID: 14665698
[TBL] [Abstract][Full Text] [Related]
16. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
17. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJ
N Engl J Med; 2001 Oct; 345(14):1030-5. PubMed ID: 11586955
[TBL] [Abstract][Full Text] [Related]
18. Beta
Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
[TBL] [Abstract][Full Text] [Related]
19. beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children.
Turner SW; Khoo SK; Laing IA; Palmer LJ; Gibson NA; Rye P; Landau LI; Goldblatt J; Le Souëf PN
Clin Exp Allergy; 2004 Jul; 34(7):1043-8. PubMed ID: 15248848
[TBL] [Abstract][Full Text] [Related]
20. Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure.
Wolk R; Snyder EM; Somers VK; Turner ST; Olson LJ; Johnson BD
J Am Soc Echocardiogr; 2007 Mar; 20(3):290-7. PubMed ID: 17336757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
